Announcements Trials
Browse Landscape

Phase

Phase 2 95Phase 3 73Phase NA 36Phase 1 23Phase 1/2 19Phase 4 2Phase 2/3 2Phase EARLY_PHASE1 1

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 3Lymphoid 3Gastrointestinal 3Head & Neck 2Genitourinary 2Classical hematology 2Breast 2Tumor-Agnostic 1Sarcoma 1Plasma cell 1Other hematologic neoplasm 1Myeloid 1Gynecologic 1Dermatologic 1CNS 1

Conditions

Prostatic Neoplasms 1Kidney Neoplasms 1Carcinoma, Renal Cell 1

Interventions

Zoledronic Acid 15enzalutamide 10Leuprolide 9Goserelin 8bicalutamide 7acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 6Triptorelin Pamoate 6Prednisone 6Nivolumab 6Abiraterone Acetate 6luprolide acetate gel depot 5Sunitinib 5Magnetic Resonance Spectroscopy 5Everolimus 5Dutasteride 5Specimen Handling 4Sodium Chloride 4Propofol 4Prednisolone 4Androgen Antagonists 42-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid 4pazopanib 3fluciclovine F-18 3darolutamide 3cabazitaxel 3Trimethoprim, Sulfamethoxazole Drug Combination 3Rocuronium 3Mitomycin 3Midazolam 3Flutamide 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 4 × Radiotherapy × Genitourinary × Clear all
NCT06903312 2025-07-03

ITALIC-RCC

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Phase 4 Recruiting
409 enrolled
Genitourinary

Carcinoma, Renal Cell, Kidney Neoplasms

NCT00590213 2008-01-25

COMART

AstraZeneca

Phase 4 Completed
125 enrolled
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡